SYNTHESIS OF MACROLIDES, STEROIDS, CYCLOPENTANOIDS ETC.
大环内酯类、类固醇类、环戊类化合物等的合成
基本信息
- 批准号:3484163
- 负责人:
- 金额:$ 28.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-06-01 至 1993-05-31
- 项目状态:已结题
- 来源:
- 关键词:amphotericin B antifungal agents antineoplastics beta lactam antibiotic conformation cyclopentane cytochalasins drug design /synthesis /production drug screening /evaluation eicosanoid metabolism ergosterol fatty acid biosynthesis female antifertility drug osteoporosis photochemistry picrotoxin progesterone prostaglandin analogs steroid biosynthesis steroids vitamin D
项目摘要
The aim of this proposal is to develop facile synthetic entries into
various classes of biologically active molecules. We are
examining the question of whether tailor-made transition metal
complexes may serve as templates to control selectivity in a way
reminiscent of enzymes. The first section deals with the
development and understanding of metal catalyzed cyclizations at
high substrate concentration and with high control
stereochemistry to form medium and large ring carbo- and
heterocycles whose biological functions include antibiotic and
antifungal activity. Some example are: 1) a 9-membered
carbocyclic ring such as pachyaldehyde, a representative of a
family of antimicrobial marine natural products, 2) a 10-
membered macrolide such as the antibiotic cephalosporilide C, 3)
an 11-membered carbocyclic ring such as the antibiotic
aspochalasin B, 4) a 12-membered metal bridged aryl cyclic ether
such as the PG synthetase inhibitor arnebinol, 5) the 14 -
membered macrolide portion of the cytochalasin antibiotics, 6)
The 17-membered para bridged antibiotic lankacidin C, and 7) The
36-membered ring system of amphotericin B, a clinically
important antifungal compound.
Cyclopentanes are a structural type of exploding biological
significance. Delicate selectivity in cyclizations will be explored
in the case of the antifungal terpene chokol C, the antimicrobials
udoteatrial and petiodial, the antibiotics enterocine and
merulidial, the pharmacologically important picrotaxane
neurotoxins, the anticonvulsant anisatin, the antibiotics punctatin
A and mellodonal, and retigeranic acid.
Mimicking enzymes with transition metal templates is examined
to improve selectivity in cycloadditions to five-membered rings.
Enzymes use substrate structural features remote from the
reaction center to control conformation and thus selectivity; the
specific introduction of such remote binding sites will be
developed for controlling cycloadditions. Especially relevant is
use of gamma -alkoxy -alpha, beta -unsaturated sulfones for 1)
asymmetric cyclopentenone annulation, 2) carbacyclin and
prostaglandin synthesis, and 3) a synthesis of ginkgolide A, a PAF
inhibitor.
The third section encompasses steroids and related terpenes using
related methodology. A short asymmetric synthesis of the A ring
and a totally new metal catalyzed reaction for forming the CD
rings of the clinically important Vitamin D metabolites will
examined. Closely related chemistry offers a simple strategy to
the novel and clinically important antifungal sicannin.
The fourth section extends these new synthetic concepts to the
beta-lactam antibiotics.
该提案的目的是开发简单的合成条目,
各种生物活性分子。 我们
研究定制的过渡金属
复合物可以作为模板以某种方式控制选择性
让人联想到酶。 第一部分涉及
金属催化环化反应的发展和认识.
高底物浓度和高控制
立体化学以形成中等和大环碳-和
杂环,其生物学功能包括抗生素和
抗真菌活性 一些例子是:1)9元
碳环如茯苓醛,其代表是
抗微生物海洋天然产物家族,2)10-
元大环内酯类,如抗生素头孢菌素C,3)
11元碳环,如抗生素
Aspochalasin B,4)12元金属桥连的芳基环醚
如PG合成酶抑制剂arnebinol,5)14 -
细胞松弛素类抗生素的三员大环内酯部分,6)
17元帕拉桥连抗生素lankacidin C,和7)
36-一种具有临床意义的抗生素--阿替霉素B,
重要抗真菌化合物。
环戊烷是一种结构类型的爆炸生物
意义 将探讨环化反应中的精细选择性
在抗真菌萜烯Chokol C的情况下,
子宫内膜和叶柄,抗生素肠肽和
merulidial,非常重要的picrotaxane
神经毒素,抗惊厥药茴香素,抗生素
美洛酮和瑞替格尔酸。
研究了以过渡金属为模板的模拟酶
以提高对五元环的环加成反应的选择性。
酶利用远离底物的结构特征,
反应中心来控制构象和选择性;
这种远程结合位点的具体引入将
用于控制环加成反应。 特别相关的是
γ-烷氧基-α,β-不饱和砜用于1)
不对称环戊烯酮成环,2)碳环素和
前列腺素合成,和3)银杏内酯A,PAF的合成
抑制剂.
第三部分包括类固醇和相关的萜烯,
相关方法。 A环的不对称短合成
和一种全新的金属催化反应形成CD
临床上重要的维生素D代谢物的环将
考察 密切相关的化学提供了一个简单的策略,
新的和临床上重要的抗真菌sicannin。
第四部分将这些新的综合概念扩展到
β-内酰胺类抗生素
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BARRY M TROST其他文献
BARRY M TROST的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BARRY M TROST', 18)}}的其他基金
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS:
抗肿瘤化合物的新合成方法:
- 批准号:
7724151 - 财政年份:2008
- 资助金额:
$ 28.35万 - 项目类别:
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC SYNTHETIC DESIGNS
大环内酯类、类固醇类、环戊类化合物等合成设计
- 批准号:
7724152 - 财政年份:2008
- 资助金额:
$ 28.35万 - 项目类别:
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC SYNTHETIC DESIGNS
大环内酯类、类固醇类、环戊类化合物等合成设计
- 批准号:
7601802 - 财政年份:2007
- 资助金额:
$ 28.35万 - 项目类别:
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: ANTIVIRALS, HIV
抗肿瘤化合物的新合成方法:抗病毒药物、HIV
- 批准号:
7601801 - 财政年份:2007
- 资助金额:
$ 28.35万 - 项目类别:
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC SYNTHETIC DESIGNS
大环内酯类、类固醇类、环戊类化合物等合成设计
- 批准号:
7369021 - 财政年份:2006
- 资助金额:
$ 28.35万 - 项目类别:
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: ANTIVIRAL AGENTS, HIV
抗肿瘤化合物的新合成方法:抗病毒药物、HIV
- 批准号:
7369020 - 财政年份:2006
- 资助金额:
$ 28.35万 - 项目类别:
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC SYNTHETIC DESIGNS
大环内酯类、类固醇类、环戊类化合物等合成设计
- 批准号:
7180903 - 财政年份:2005
- 资助金额:
$ 28.35万 - 项目类别:
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: ANTIVIRAL AGENTS, HIV
抗肿瘤化合物的新合成方法:抗病毒药物、HIV
- 批准号:
7180902 - 财政年份:2005
- 资助金额:
$ 28.35万 - 项目类别:
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: ANTIVIRAL AGENTS, HIV
抗肿瘤化合物的新合成方法:抗病毒药物、HIV
- 批准号:
6976589 - 财政年份:2004
- 资助金额:
$ 28.35万 - 项目类别:
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC SYNTHETIC DESIGNS
大环内酯类、类固醇类、环戊类化合物等合成设计
- 批准号:
6976590 - 财政年份:2004
- 资助金额:
$ 28.35万 - 项目类别:
相似海外基金
Extending the utility and durability of antifungal agents via innovative treatment regimens that minimise drug resistance
通过创新治疗方案最大限度地减少耐药性,延长抗真菌药物的效用和持久性
- 批准号:
MR/Y002164/1 - 财政年份:2024
- 资助金额:
$ 28.35万 - 项目类别:
Research Grant
Engineering microbial cell factories for production of improved polyene antifungal agents
工程微生物细胞工厂用于生产改进的多烯抗真菌剂
- 批准号:
2898887 - 财政年份:2023
- 资助金额:
$ 28.35万 - 项目类别:
Studentship
Morphological profiling for the development of antifungal agents
用于开发抗真菌药物的形态分析
- 批准号:
22H02216 - 财政年份:2022
- 资助金额:
$ 28.35万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
An efficient approach to find therapeutically effective antifungal agents
寻找治疗有效的抗真菌药物的有效方法
- 批准号:
22K05337 - 财政年份:2022
- 资助金额:
$ 28.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating light-activated therapeutic compounds as antifungal agents.
研究光激活治疗化合物作为抗真菌剂。
- 批准号:
2753345 - 财政年份:2022
- 资助金额:
$ 28.35万 - 项目类别:
Studentship
Discovery of novel therapeutic agents for biliary tract and pancreatic cancer based on antifungal agents
基于抗真菌药物的胆道癌和胰腺癌新型治疗药物的发现
- 批准号:
20H03533 - 财政年份:2020
- 资助金额:
$ 28.35万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of antifungal agents that target essential protein kinases in A. fumigatus.
开发针对烟曲霉必需蛋白激酶的抗真菌剂。
- 批准号:
2456629 - 财政年份:2020
- 资助金额:
$ 28.35万 - 项目类别:
Studentship
Elucidation of tip growth factor of fungi and construction of screeing system for antifungal agents
真菌尖端生长因子的阐明及抗真菌药物筛选体系的构建
- 批准号:
19K05738 - 财政年份:2019
- 资助金额:
$ 28.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Ambruticins: An inspiration to develop novel biocatalysts and antifungal agents
Ambruticins:开发新型生物催化剂和抗真菌剂的灵感
- 批准号:
2107517 - 财政年份:2018
- 资助金额:
$ 28.35万 - 项目类别:
Studentship














{{item.name}}会员




